Head to Head Survey: PetMed Express (NASDAQ:PETS) and Leafly (NASDAQ:LFLYW)

Leafly (NASDAQ:LFLYWGet Free Report) and PetMed Express (NASDAQ:PETSGet Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their dividends, profitability, institutional ownership, risk, analyst recommendations, earnings and valuation.

Earnings and Valuation

This table compares Leafly and PetMed Express’ revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Leafly $42.25 million N/A N/A N/A N/A
PetMed Express $256.86 million 0.34 $5.14 million ($0.39) -10.68

PetMed Express has higher revenue and earnings than Leafly.

Institutional and Insider Ownership

73.3% of PetMed Express shares are held by institutional investors. 3.6% of PetMed Express shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current ratings for Leafly and PetMed Express, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Leafly 0 0 0 0 N/A
PetMed Express 1 0 1 0 2.00

PetMed Express has a consensus target price of $13.25, indicating a potential upside of 218.13%. Given PetMed Express’ higher possible upside, analysts clearly believe PetMed Express is more favorable than Leafly.

Profitability

This table compares Leafly and PetMed Express’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Leafly N/A N/A N/A
PetMed Express -2.92% -1.25% -0.75%

Summary

PetMed Express beats Leafly on 5 of the 8 factors compared between the two stocks.

About Leafly

(Get Free Report)

Leafly Holdings, Inc. owns and operates a platform to provide consumers with cannabis information and connects consumers to cannabis brands and licensed retailers. The company offers subscription-based marketplace listings, digital advertising solutions, and software as a service-based tools to cannabis retailers and brands; and information, reviews, menus, and ordering and delivery options to its audience through its website and mobile applications. Leafly Holdings, Inc. was founded in 2010 and is headquartered in Seattle, Washington.

About PetMed Express

(Get Free Report)

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds, PetCare Rx, and PetMeds brands. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

Receive News & Ratings for Leafly Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Leafly and related companies with MarketBeat.com's FREE daily email newsletter.